Daniel Lamarre

NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent.

Martin Poirier, P. Bonneau, D. Lamarre, 2004, Journal of medicinal chemistry.

Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.

Martin Poirier, D. Lamarre, M. Poirier, 2004, Journal of medicinal chemistry.

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.

P. Bonneau, D. Lamarre, H. Nar, 2003, Angewandte Chemie.

Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches*

Vincent Lotteau, Pierre Thibault, Éric Bonneil, 2013, Molecular & Cellular Proteomics.

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Steven R. LaPlante, P. Bonneau, D. Lamarre, 2003, Nature.

Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.

Martin Poirier, M. Garneau, D. Lamarre, 2004, Journal of medicinal chemistry.